molecular

CTO Genetic Analysis Finalist in Innovation Challenge Lyfebulb and Bristol Myers Squibb Addresses Unmet Need in IBD

by

Oslo, NorwayAnd January 27, 2023 – Molecular Diagnostic Specialist, AS genetic evaluation (“GA”) pronounces the appointment of a Director of Expertise for GA Curry Foro He was a finalist within the Lyfebulb Innovation Problem 2022 in collaboration with Bristol-Myers Squibb (“BMS”) for unmet want in inflammatory bowel illness (“IBD”). GA’s launched Curry IBD Biomarker Mission … Read more

AS Genetic Analysis Company has obtained the Thai Food and Drug Administration’s authorization to test GA-map Dysbiosis in Thailand

by

Oslo, Norway – January 19, 2023: Molecular Diagnostic Specialist, AS genetic evaluation (“GA”) declares that Meals and Drug Administration of Thailand (“Thai FDA”) has granted GA authorization for the GA-map® Dysbiosis Check in Thailand. GA has, in affiliation with its distributor Hausen Bernstein Co. Ltd. (“HB”) filed for regulatory approval for the GA-map® Dysbiosis Check … Read more